Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.22.4
Stockholders' Equity (Tables)
12 Months Ended
Sep. 30, 2022
Stockholders' Equity  
Schedule of warrants issued and outstanding

Expiration date

    

Exercise Price

    

Warrants Outstanding

July 6, 2023

$

8.73

 

105,000

September 20, 2024

6.50

75,000

 

180,000

    

    

    

Weighted-

Weighted-

Average

Average

Remaining 

Exercise

Contractual Life

Warrants

Price

(in years)

Outstanding as of September 30, 2020

 

820,939

$

19.44

 

Issued

75,000

6.50

Outstanding as of September 30, 2021

895,939

18.35

0.9

Expired

(715,939)

21.01

Outstanding as of September 30, 2022

180,000

7.80

1.3

Exercisable as of September 30, 2022

 

180,000

7.80

 

1.3

Schedule of key assumptions used to estimate the fair value of the advisory warrants granted

    

As of September 30, 

 

2021

Remaining contractual term (years)

 

3.0

Common stock price volatility

 

83.9

%

Risk-free interest rate

 

0.5

%

Expected dividend yield